Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects.
Toyanji J PunchaichiraAnirban MukhopadhyayPrachi KukshalTriptish BhatiaSmita N DeshpandeThelma B KPublished in: Journal of psychopharmacology (Oxford, England) (2020)
With modest genotype-phenotype correlations available for DBH variants, personalized treatment regimens based on DBH activity for ameliorating tardive dyskinesia and cognitive symptoms may be plausible.